P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors
Poseida Therapeutics, Inc.
Poseida Therapeutics, Inc.
SystImmune Inc.
University of Nebraska
Takeda
Novartis
Travera Inc
Eastern Cooperative Oncology Group
Xencor, Inc.
Sun Yat-sen University
University of Wisconsin, Madison
Stanford University
University Health Network, Toronto
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)
National Cancer Institute (NCI)